SCHEMBL29795641

SCHEMBL29795641

CC(=O)N1CCN(c2cccc(N)c2N)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.60
CASP6 P55212 1/20 0.53
GFER P55789 1/20 0.53
NCF1 P14598 2/20 0.50
KDM4E B2RXH2 2/20 0.45
HTR6 P50406 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ADRA2C P18825 1/20 0.45
NPSR1 Q6W5P4 2/20 0.43
USP2 O75604 2/20 0.43
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
TSHR P16473 1/20 0.43
LMNA P02545 1/20 0.42
MAPT P10636 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23124284 1.00 ALDH1A1 (0.60) ALDH1A1CASP6GFERNCF1KDM4E
SCHEMBL12890006 0.87 ADRA2C (0.61) ALDH1A1CASP6GFERNCF1KDM4E
SCHEMBL3312656 0.86 ALDH1A1 (0.72) ALDH1A1CASP6GFERNCF1KDM4E
SCHEMBL10377137 0.84 ALDH1A1 (0.57) ALDH1A1CASP6GFERNCF1KDM4E
SCHEMBL29795506 0.83 TSHR (0.53) ALDH1A1NPSR1USP2MEN1KMT2A
SCHEMBL23123793 0.83 TSHR (0.53) ALDH1A1NPSR1USP2MEN1KMT2A
SCHEMBL17738756 0.82 ALDH1A1 (0.55) ALDH1A1CASP6GFERNCF1KDM4E
SCHEMBL17739013 0.82 ALDH1A1 (0.55) ALDH1A1CASP6GFERNCF1KDM4E
SCHEMBL31152780 0.81 SMARCA2 (0.55) ALDH1A1SMN1; SMN2MEN1KMT2ALMNA
SCHEMBL1249642 0.81 SMARCA2 (0.55) ALDH1A1SMN1; SMN2MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4031532-A1 SUBSTITUTED BENZIMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS Bial-R&D Investments, S.A. (PT) 2022-07-27 EP disclosed